Form 8-K - Current report:
SEC Accession No. 0001193125-25-004142
Filing Date
2025-01-10
Accepted
2025-01-10 08:27:00
Documents
50
Period of Report
2025-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837783d8k.htm   iXBRL 8-K 30292
2 EX-99.1 d837783dex991.htm EX-99.1 27764
3 EX-99.2 d837783dex992.htm EX-99.2 45821
8 GRAPHIC g837783ex99_2p10g1.jpg GRAPHIC 252739
9 GRAPHIC g837783ex99_2p11g1.jpg GRAPHIC 328469
10 GRAPHIC g837783ex99_2p12g1.jpg GRAPHIC 239096
11 GRAPHIC g837783ex99_2p13g1.jpg GRAPHIC 210429
12 GRAPHIC g837783ex99_2p14g1.jpg GRAPHIC 218592
13 GRAPHIC g837783ex99_2p15g1.jpg GRAPHIC 234196
14 GRAPHIC g837783ex99_2p16g1.jpg GRAPHIC 200814
15 GRAPHIC g837783ex99_2p17g1.jpg GRAPHIC 193317
16 GRAPHIC g837783ex99_2p18g1.jpg GRAPHIC 311639
17 GRAPHIC g837783ex99_2p19g1.jpg GRAPHIC 166789
18 GRAPHIC g837783ex99_2p1g1.jpg GRAPHIC 463102
19 GRAPHIC g837783ex99_2p20g1.jpg GRAPHIC 286225
20 GRAPHIC g837783ex99_2p21g1.jpg GRAPHIC 202339
21 GRAPHIC g837783ex99_2p22g1.jpg GRAPHIC 355033
22 GRAPHIC g837783ex99_2p23g1.jpg GRAPHIC 297423
23 GRAPHIC g837783ex99_2p24g1.jpg GRAPHIC 364961
24 GRAPHIC g837783ex99_2p25g1.jpg GRAPHIC 304067
25 GRAPHIC g837783ex99_2p26g1.jpg GRAPHIC 190621
26 GRAPHIC g837783ex99_2p27g1.jpg GRAPHIC 311744
27 GRAPHIC g837783ex99_2p28g1.jpg GRAPHIC 363300
28 GRAPHIC g837783ex99_2p29g1.jpg GRAPHIC 239834
29 GRAPHIC g837783ex99_2p2g1.jpg GRAPHIC 748428
30 GRAPHIC g837783ex99_2p30g1.jpg GRAPHIC 214870
31 GRAPHIC g837783ex99_2p31g1.jpg GRAPHIC 487360
32 GRAPHIC g837783ex99_2p32g1.jpg GRAPHIC 252885
33 GRAPHIC g837783ex99_2p33g1.jpg GRAPHIC 333523
34 GRAPHIC g837783ex99_2p34g1.jpg GRAPHIC 364348
35 GRAPHIC g837783ex99_2p3g1.jpg GRAPHIC 430467
36 GRAPHIC g837783ex99_2p4g1.jpg GRAPHIC 258595
37 GRAPHIC g837783ex99_2p5g1.jpg GRAPHIC 299878
38 GRAPHIC g837783ex99_2p6g1.jpg GRAPHIC 347591
39 GRAPHIC g837783ex99_2p7g1.jpg GRAPHIC 231515
40 GRAPHIC g837783ex99_2p8g1.jpg GRAPHIC 275742
41 GRAPHIC g837783ex99_2p9g1.jpg GRAPHIC 292859
  Complete submission text file 0001193125-25-004142.txt   14442597

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nams-20250110.xsd EX-101.SCH 3569
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20250110_def.xml EX-101.DEF 13773
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20250110_lab.xml EX-101.LAB 22357
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20250110_pre.xml EX-101.PRE 14561
52 EXTRACTED XBRL INSTANCE DOCUMENT d837783d8k_htm.xml XML 5726
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 25520563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)